The synthesis and 14 -labeling of 3α,7α,12α-trihydroxy-27-carboxymethyl-5-β-cholestan-26-oic acid by two different approaches is described. One of them involves chain elongation of cholic acid via Wittig-Horner condensation of its formylated 24-aldehyde with tetraethyl phosphonoglutarate. The resulting cholestenoate, on deprotection and hydrogenation, affords the unusual C 29 bile acid in good yield. An alternative procedure consists in a malonic ester synthesis starting from the formulated 24-alcohol which, after conversion into a mesylate, is reacted with sodium salt of 2-carboethoxy-γ-butyrolactone. Alkaline hydrolysis, decarboxylation, esterification with diazomethane and selective tosylation of the newly introduced primary hydroxyl function give a C 28 precursor, which is easily chain-elongated into a labeled or unlabeled C 29 bile acid by reaction with cyanide and hydrolysis. Due to easy lactonization of some of the C 28 intermediates, the latter method provides a better way for introducing a C-29 label than the sequence usually employed for carboxyl labeling of bile acids and consisting in a decarboxylative halogenation of the parent acid followed by substitution of the norhalogenide with [ 14C]cyanide and hydrolysis. The structure of the synthesized acid or its dimethyl ester is confirmed by 13C nuclear magnetic resonance spectroscopy and mass spectrometry, and is also shown by gas liquid chromatography to be identical with an authentic sample of biosynthesis C 29 dioic bile acid extracted from body fluids of Zellweger patients.
Read full abstract